Camlin Fine Sciences has informed that Centrum Capital (Manager to the Offer) has submitted a copy of Detailed Public Statement under Regulations 3(1) and 4 read with Regulations 13(4), 14(3), 15(2) and other applicable Regulations of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, to the Eligible Public Shareholders of Camlin Fine Sciences (Target Company).
The above information is a part of company’s filings submitted to BSE.
